Answers are grounded in this paper and cite their sources.
Background Catastrophic health expenditure (CHE) is one of the major hindrances to achieving universal health coverage. This study investigated the prevalence and correlates of catastrophic health expenditure among patients at Jinja Regional Referral Hospital (RRH), Uganda. Methods The study sample consisted of 224 adults (≥ 18 years) systematically sampled from outpatient (n = 123) and inpatient (n = 101) departments between August and November 2022. Structured interviews were used to determine out-of-pocket expenditure and household non-food expenditure. CHE was defined as out-of-pocket expenditure exceeding 10% of monthly household non-food expenditure. Analysis was performed using SPSS v25. Descriptive statistics were calculated, and log-binomial regression was used to produce crude and adjusted prevalence ratios (cPR and aPR) with 95% confidence intervals (CIs). Study reporting adhered to STROBE guidelines for cross-sectional studies. Results CHE prevalence was 34.8% (78/224), and 71.4% (160/224) of patients incurred out-of-pocket payments, driven primarily by medicines (45.0%) and transport (30.0%). Patient-level correlates of lower CHE risk included female sex (aPR = 0.62, 95% CI: 0.40–0.96, p = .034) and secondary O-level education versus post-secondary education (aPR = 0.54, 95% CI: 0.30–0.96, p = .036). Household-level correlates showed that female-headed households (aPR = 0.69, 95% CI: 0.48–0.99, p = .044) and households with four members (aPR = 0.11, 95% CI: 0.02–0.76, p = .025) had lower risk. Having one child under five years (aPR = 0.56, 95% CI: 0.34–0.94, p = .027) or two children under five years (aPR = 0.45, 95% CI: 0.23–0.88, p = .019) reduced risk compared to more than three children, while households with members aged 65 years or older had significantly higher risk (aPR = 1.55, 95% CI: 1.11–2.15, p = .010). Conclusions CHE was high at 35% despite public user fee abolition, and household factors showed stronger correlations with CHE than individual factors. Interventions must target pharmaceutical supply chains and vulnerable groups—including households with elderly members and large male-headed households—to advance universal health coverage.
No takes yet. Share an insight, caveat, or question.
Bwanika et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: